Podcasts about evaluate

 In an ever-changing dating world, it can be hard to stay positive.   We often have two choices, we can be optimistic or pessimistic.  The NYT reports that optimists earn more money, have better relationships, and even live longer!   Today, I will explain to you not only how to rewire your brain for optimism, but PSYCHOTIC OPTIMISM!   Psychotic optimism is something Smart Dating Academy is renowned for, (believing in your CORE that love exists for you) and today, we pull back the curtain on our best techniques to become a psychotic optimist!   And yes, optimism can be learned - you don't have to be born with it!    You will learn how to: Identify the negative voice in your head, give it a name, and TALK BACK TO IT! Reframe Situations, Positively Reframing Them (so important)!    How to make 2 lists that can bring you JOY (and avoid pain) How to Evaluate the Company you Keep and decide if they're good for you or Debbie Downers!    Why volunteering is good for your mind and soul Why Gratitude is KEY and why you should religiously write down 3 things you're grateful for. Exercise -- Get the Dopamine GOING! Do something you're afraid of every day. Make a playlist of happy songs!!    Connect with a friend or family member you haven't talked to in a while And, most importantly, Peak Dating Season is coming up - so it's time to AMP UP the psychotic optimism!   It's time to get your profile in EXCELLENT shape - and there is nothing better you can do than schedule a one hour consultation with us to make sure you're at the top of your game.  Email datecoach@smartdatingacademy.com, or check our website for more details :) Join our free newsletter database by signing up here:  www.smartdatingacademy.com/contact Follow us on Instagram at @smartdatingacademy Schedule your consultation with us here!   We are on a waiting list, and would love to help you!  https://www.smartdatingacademy.com/11-coaching/coaching-call-with-bela

Customers are fickle. Or at least they appear to be. What once may have exceeded your customer's expectations one day becomes ordinary the next. That's because People become less sensitive to change as things improve. It's called  Diminishing Sensitivity, and it's the reason that sometimes you have to work harder to “Wow!” your customers.     If you gave $100 to a poor person and a millionaire, it would have completely different effects on their daily lives. While the millionaire would be polite and appreciative of the extra cash, the poor person would feel the difference made by the money far more.    In some ways, your customers are the millionaire in this scenario. Your excellent Customer Experience has made them less sensitive to your improvements. However, if your experience is next to terrible, improvements feel a lot more like $100 to a poor person.    Diminishing sensitivity can be seen across many different industries. For example, the difference in graphics between the video game Football for the Atari 2600 and Madden's NFL 10 was astounding. However,  when you compare Madden 10 to Madden 12 and 14, the difference is noticeable, but not astounding. It ceases to be something that amazes and becomes something to be expected.   In this episode, we explore the concept of diminishing sensitivity and how it  can affect your customer experience and your customers' perception of it. We also talk about what you can do to continue to improve.    How Can I Combat Diminishing Sensitivity?   While it would be easy to say you should constantly push the boundaries of your product or service, this is not necessarily realistic. As we have seen with the iPhone, constant improvement eventually bores consumers. Therefore, it's essential to occasionally disrupt the market with more significant improvements to keep your customers hooked.     Here are some other key moments: 03:33   Ryan introduces the concept of diminishing sensitivity and the minds behind the concept. 09:07   Colin and Ryan discuss how the iPhone is an example of diminishing sensitivity. 15:09    Colin admits that he likes to find companies that need his help that haven't gone as far into their experience journey because you can enjoy significant impact quickly.  19:14    Ryan and Colin explain how other large organizations have navigated the tricky bit of continuous improvement after enjoying those initial gains. 25:50    Ryan and Colin go over the “curse of improvement” and what you can do to avoid it.   Did you know we have a YouTube Channel too? Check it out here.   Please tell us how we are doing! Complete this short survey.    Customer Experience Information & Resources   LinkedIn recognizes Colin Shaw as one of the 'World's Top 150 Business Influencers.' As a result, he has 290,000 followers of his work. Shaw is Founder and CEO of Beyond Philosophy LLC, which helps organizations unlock growth by discovering customers' hidden, unmet needs that drive value ($). The Financial Times selected Beyond Philosophy as one of the best management consultancies for the last four years in a row. Follow Colin on LinkedIn and Twitter.   Click here to learn more about Professor Ryan Hamilton of Emory University.    Why Customers Buy: As an official "Influencer" on LinkedIn, Colin writes a regular newsletter on all things Customer Experience. Click here to join the other 35,000 subscribers.    How can we help? Click here to learn more about Beyond Philosophy's Suite of Services.

Customers are fickle. Or at least they appear to be. What once may have exceeded your customer's expectations one day becomes ordinary the next. That's because People become less sensitive to change as things improve. It's called  Diminishing Sensitivity, and it's the reason that sometimes you have to work harder to “Wow!” your customers.     If you gave $100 to a poor person and a millionaire, it would have completely different effects on their daily lives. While the millionaire would be polite and appreciative of the extra cash, the poor person would feel the difference made by the money far more.    In some ways, your customers are the millionaire in this scenario. Your excellent Customer Experience has made them less sensitive to your improvements. However, if your experience is next to terrible, improvements feel a lot more like $100 to a poor person.    Diminishing sensitivity can be seen across many different industries. For example, the difference in graphics between the video game Football for the Atari 2600 and Madden's NFL 10 was astounding. However,  when you compare Madden 10 to Madden 12 and 14, the difference is noticeable, but not astounding. It ceases to be something that amazes and becomes something to be expected.   In this episode, we explore the concept of diminishing sensitivity and how it  can affect your customer experience and your customers' perception of it. We also talk about what you can do to continue to improve.    How Can I Combat Diminishing Sensitivity?   While it would be easy to say you should constantly push the boundaries of your product or service, this is not necessarily realistic. As we have seen with the iPhone, constant improvement eventually bores consumers. Therefore, it's essential to occasionally disrupt the market with more significant improvements to keep your customers hooked.     Here are some other key moments: 03:33   Ryan introduces the concept of diminishing sensitivity and the minds behind the concept. 09:07   Colin and Ryan discuss how the iPhone is an example of diminishing sensitivity. 15:09    Colin admits that he likes to find companies that need his help that haven't gone as far into their experience journey because you can enjoy significant impact quickly.  19:14    Ryan and Colin explain how other large organizations have navigated the tricky bit of continuous improvement after enjoying those initial gains. 25:50    Ryan and Colin go over the “curse of improvement” and what you can do to avoid it.   Did you know we have a YouTube Channel too? Check it out here.   Please tell us how we are doing! Complete this short survey.    Customer Experience Information & Resources   LinkedIn recognizes Colin Shaw as one of the 'World's Top 150 Business Influencers.' As a result, he has 290,000 followers of his work. Shaw is Founder and CEO of Beyond Philosophy LLC, which helps organizations unlock growth by discovering customers' hidden, unmet needs that drive value ($). The Financial Times selected Beyond Philosophy as one of the best management consultancies for the last four years in a row. Follow Colin on LinkedIn and Twitter.   Click here to learn more about Professor Ryan Hamilton of Emory University.    Why Customers Buy: As an official "Influencer" on LinkedIn, Colin writes a regular newsletter on all things Customer Experience. Click here to join the other 35,000 subscribers.    How can we help? Click here to learn more about Beyond Philosophy's Suite of Services.

Being an expert in user experience doesn't mean that you're an expert designer or programmer. User experience is about how constituents experience your nonprofit organization. Learn five user experience “hacks” that come before technology—and how to create a “user-centric” experience of your organization. In pt 2 of this webinar hosted by Community IT Innovators' Johan Hammerstrom, Kyle Haines, Co-Founding Partner of Build Consulting, answers registrant and attendee questions to dig a little deeper into the concepts and how they can transform your thinking about your tech projects. The Five Hacks Agree that user experience is important Focus on staff experience Evaluate your physical environment Map your constituent journeys Collect and act on feedback

SGLT2 inhibitors, publishing choices, second and third order effects of interventions, decision support, and patient selection for preventive procedures are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. EMPA Kidney - EMPA-Kidney Seals SGLT2 Inhibitors as 'Foundational' for CKD https://www.medscape.com/viewarticle/984439 - EMPA-Kidney Moves the Needle for SGLT2 Inhibitors in Kidney Disease https://www.medscape.com/viewarticle/983521 - Empagliflozin in Patients with Chronic Kidney Disease https://www.nejm.org/doi/pdf/10.1056/NEJMoa2204233 - Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy https://www.nejm.org/doi/10.1056/NEJMoa1811744 - Dapagliflozin in Patients with Chronic Kidney Disease https://www.nejm.org/doi/full/10.1056/NEJMoa2024816 - Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials https://doi.org/10.1016/S0140-6736(22)02074-8 II. Publishing Choices - Motorcycle Rallies Linked to Spike in Organ Transplants https://www.medscape.com/viewarticle/984623 - Organ Donation and Transplants During Major US Motorcycle Rallies https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2798550 III. Second and Third Order Effects - Heart Disease Deaths Spiked During COVID After 10-Year Decline https://www.medscape.com/viewarticle/984605 IV. Decision Support - Patient App Aids Decisions on Anticoagulants: ENHANCE-AF https://www.medscape.com/viewarticle/984253 - A Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway https://www.ahajournals.org/doi/10.1161/JAHA.122.028562 V. Percutaneous Left Atrial Appendage Closure - Consider Life Expectancy When Referring for LAA Closure? https://www.medscape.com/viewarticle/981117 - Transcatheter Left Atrial Appendage Occlusion: A Multi-Center Real Life Experience https://www.mdpi.com/2077-0383/11/23/6944 - Incidence and Predictors of Early Death in Patients Undergoing Percutaneous Left Atrial Appendage Closure https://www.jacc.org/doi/full/10.1016/j.jacep.2022.06.012 - Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry https://www.ahajournals.org/doi/full/10.1161/CIRCOUTCOMES.121.008418 You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Justin Gordon (@justingordon212) talks with Richard Kerby (@kerby), Co-Founder and General Partner at Equal Ventures, a seed stage focused fund backing the founders and businesses transforming society and industry. Prior to Equal Ventures, Richard was an investor at Venrock, where he led seed stage and Series A stage investments in 6Sense, Amino Apps, Beckon, Burner, Luxe Valet, and Salsify. Prior to joining Venrock, Richard was an investor at Institutional Venture Partners (IVP), where he focused on identifying and evaluating later-stage investments. While at IVP, Richard worked with IVP portfolio companies such as Dropbox, FleetMatics, PopSugar, Shazam, and Yext. Previously, Richard worked in the Investment Banking Division of Credit Suisse. Richard is a proud Georgetown alum and is a rabid Hoyas basketball fan. He is also the founder of Stealth Mode, a community of more than 1,500 African American founders, operators and investors.Website: Equal VenturesLinkedIn: linkedin.com/in/richardkerby/Twitter: @kerbyEmail: kerby@equal.vcShow Notes: Equal Ventures' investment thesis and the strategy behind being generalists Deciding to start a fund instead of joining an existing one Richard's key learnings as an emerging manager What being hands-on with their founders means at Equal Ventures Their all “hands on deck” approach to building the Equal Ventures team Running the Emerging Managers Circle and deciding to host summits Trends Richard is excited about Richard's view on remote vs. in-person How Equal Ventures evaluates founders Richard's advice for emerging managers More about the show:The Vitalize Podcast, a show by Vitalize Venture Capital (a seed-stage venture capital firm and pre-seed 400+ member angel community open to everyone), dives deep into the world of startup investing and the future of work.Hosted by Justin Gordon, the Director of Marketing at Vitalize Venture Capital, The Vitalize Podcast includes two main series. The Angel Investing series features interviews with a variety of angel investors and VCs around the world. The goal? To help develop the next generation of amazing investors. The Future of Work series takes a look at the founders and investors shaping the new world of work, including insights from our team here at Vitalize Venture Capital. More about us:Vitalize Venture Capital was formed in 2017 as a $16M seed-stage venture fund and now includes both a fund as well as an angel investing community investing in the future of work. Vitalize has offices in Chicago, San Francisco, and Los Angeles.The Vitalize Team:Gale - https://twitter.com/galeforceVCCaroline - https://twitter.com/carolinecasson_Justin - https://twitter.com/justingordon212Vitalize Angels, our angel investing community open to everyone:https://vitalize.vc/vitalizeangels/

This week I talk to Jennifer Sutto about content creation and the new chat-based NFT swapping platform from Evaluate.xyz. https://twitter.com/jennifer_sutto https://evaluate.xyz/ ——My Podcasting Gear: Cameras, Mics, and Lights——Do you need help developing your brand and business?Work with me at SPYR!Mint or collect NFTs from projects that I've worked on: SkullKids: Generations (Mint | OpenSea) The Spoopies (Mint) Frootlings (Mint | OpenSea) The Ooglies (OpenSea) ——Enjoying the show? Let me know on Twitter! I'm @jeffSARRIS.Watch Starting Now on YouTube or listen and subscribe on Apple Podcasts, Spotify, or wherever you get your podcasts.——A huge thanks goes out to Amara Andrew for handling the live video production on Starting Now. Follow what she's up to or hire her for your video production needs at mavenbyamara.com!——Some of the links above may be affiliate links which means that I earn a small commission from qualifying purchases at no additional cost to you. Thanks for your support!

The job market is extremely hot right now, and many people are looking to build their careers and shift into better roles. But how do you evaluate different content marketing job opportunities to make sure you pick the best one? In this episode of the Content Logistics podcast, our host Camille Trent talks about the most vital factors to consider when evaluating your career path. She shares some tips for understanding whether a specific role or a company is the right choice for you. 

How do you connect with your intuition? Do others connect with their intuition? How do you talk about what you cannot see? How do you talk to others about psychic abilities? How can you tell when someone is open to the unseen? How do we normalize spirituality?  Ideally, we would all be able to enter into any space with any person and be able to have an open conversation while feeling safe and accepted. However, because each person is on their own path and in a different place in their spiritual journey, not everyone will be ready to hear about or discuss spirituality without becoming defensive or rooted in judgment.  In this episode of Love Always, Self, Karista & Shyra discuss how to create an atmosphere that normalizes discussing spiritual growth and connecting with unseen things, like intuition or spiritual guides. Like all things, this practice starts by looking within and creating that safe internal space to be you.  Evaluate your judgment of your spiritual growth. Have you accepted your ability to connect? Ask yourself what is the story you're telling yourself? Are you speaking negatively about yourself to yourself? How can you alter your story to emphasize self-love, self-worth, and self-confidence? How can you adjust your state of being to accept others where they are at and be open to someone surprising you with their curiosity? Do you need to release the judgment of others and maintain your own sense of curiosity in this mission of discovery? How can you do a “heat check” in a conversation? : Announcements: We've launched Divine Living: Style & Decor! Let us help you embrace your space! https://www.divinelivingstyledecor.com/ Now you can shop our Amazon Favorites on our website! https://www.lovealwaysself.com/amazon-favorites : Episode Suggestions: Episode 78: Where Your Attention Goes Your Energy Flows; Be What You Want To See In The World Episode 76: What Is The Story You're Telling Yourself? How Your Thoughts Play A Part Episode 75: Taking Your Own Advice Through Journaling Episode 73: Shifting Perspectives: Deciding On The Perspective Episode 34: Do We Create Our Own Suffering? Episode 31: Connect w/Source by Connecting w/Self Episode 20: It's Time To Play; Incorporating Play In Our Everyday Lives : Social Media:  Website - https://www.lovealwaysself.com/ Linktree - https://linktr.ee/lovealwaysself Have a topic you'd like us to discuss? Email Us!: contact@lovealwaysself.com  : #love #selflove #spiritual #heatcheck #spirituality #spiritualgrowth #intuition #psychicabilities #growth #awareness #reflection #whatareyoutellingyourself #observation #selfobservation #conscious #selfreflections #reflectionsofself #godeeper #curiosity #connection #compassion #collectiveconscious #discernement #interconnected #releasejudgment #MTGLASS #Source #opentoreceive #lovealwaysself #lovealwaysselfpodcast

Go online to PeerView.com/XZA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. This unique video-based activity will offer learners a window into practice by featuring a series of expert-led lectures that will seamlessly link the latest scientific evidence on CAR-T therapy across a range of hematologic malignancies with panel-based insights on clinical decision-making. Each session will include a Tumor Board segment designed to reflect real-world clinical experiences and decision challenges, from identifying patient candidates to appropriate follow-up and the management of a unique spectrum of adverse events. Upon completion of this CE activity, participants will be able to: Evaluate the latest clinical evidence on the safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies in patients with hematological malignancies across existing and potential future indications; Adopt best practices for integrating CAR-T therapy into the care of patients with hematologic malignancies, including appropriate patient selection, referral to specialized treatment centers, clinical trial enrollment, and provision of post-treatment follow-up care; and Develop appropriate adverse event management strategies for patients with hematological malignancies who are experiencing toxicity (eg, cytokine release syndrome or neurotoxicity) while receiving CAR-T therapy.

Go online to PeerView.com/XZA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. This unique video-based activity will offer learners a window into practice by featuring a series of expert-led lectures that will seamlessly link the latest scientific evidence on CAR-T therapy across a range of hematologic malignancies with panel-based insights on clinical decision-making. Each session will include a Tumor Board segment designed to reflect real-world clinical experiences and decision challenges, from identifying patient candidates to appropriate follow-up and the management of a unique spectrum of adverse events. Upon completion of this CE activity, participants will be able to: Evaluate the latest clinical evidence on the safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies in patients with hematological malignancies across existing and potential future indications; Adopt best practices for integrating CAR-T therapy into the care of patients with hematologic malignancies, including appropriate patient selection, referral to specialized treatment centers, clinical trial enrollment, and provision of post-treatment follow-up care; and Develop appropriate adverse event management strategies for patients with hematological malignancies who are experiencing toxicity (eg, cytokine release syndrome or neurotoxicity) while receiving CAR-T therapy.

The guys are back to chat about the playoff rankings, The Gators' season, and the rest of the news around the country. Do Vol fans have a right to be mad?Was 6-6 for Napier at UF a "Good " Season? Playoff Talk As always, we want to remind people that we are a licensed product brand doing this podcast as fun football talk that we have around the office. We are officially licensed for over 300+ universities with our flagship Stainless Steel Drinkware brand-so we root for everyone! Check us out at www.gametimesidekicks.com

Urothelial Carcinoma: Advances in Immuno-Oncology Host: Jay D. Raman, MD, FACS Co-Hosts: Andrea Apolo, MD and Sima Porten, MD CME Available: auau.auanet.org/node/37325 At the conclusion of this activity, participants will be able to 1. Determine the pros/cons of sequencing strategies with chemotherapy and immunotherapy in first line metastatic urothelial carcinoma. 2. Prioritize treatment options in first line metastatic urothelial carcinoma. 3. Evaluate second line options for metastatic urothelial carcinoma. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

2023 is going to be here before we know it. The new year is always filled with energy, momentum, and the desire for a fresh start. That usually kicks off goal setting and initiatives. You may even pick a word for the year. Instead of waiting until January to think about what you want in 2023, start now by self-examining your life now to get a clear picture of where you are, what you value and need, before setting goals.In this episode, Astrid and Alexis share the importance to being honest with yourself, your tendencies, and knowing your core values first instead of jumping into goal setting.

$2 Billion recovered in the past 10 years. 10,000 active cases across eight locations. Lawyer of the Year and scores of accolades. Brett Schreiber, Partner at Singleton Schreiber, credits his success in trial and business to one thing: being present. Brett is able to tap into flow states so often because he is both clear on his limitations and knows how to put the best people in positions to do the rest. From hiring to referrals and serving the community Brett wants whats best fro everyone involved. He understands that we are all in this together. Today, he shares how to keep that "small firm" feel when your caseload is in the tens of thousands, as well as the tools a firm of that size uses to keep the train on the tracks. And why parenting can make you a better trial attorney and what mindfulness has to do with running a successful firm.Key takeaways: Develop better habits. We are the sum of our daily actions. To get to where you want to be, pay attention to the little choices that can make you 1% better.  Understand your limitations.  Fill in the gaps by bringing on people who are great at what they do. So you can do more of what you're good at.  Evaluate and iterate. As you scale be willing to reevaluate the systems you have set up. what served you months ago might not get the job done today or in the future with an increased caseload.  Links and Resources Tip The Scales Podcast Tip the Scales Instagram Maria Monroy Instagram Maria Monroy LinkedIn LawRank Website LawRank Instagram LawRank Facebook LawRank LinkedIn LawRank Twitter Singleton Schreiber Website Brett Schreiber LinkedIn Singleton Schreiber Instagram

Go online to PeerView.com/XZA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. This unique video-based activity will offer learners a window into practice by featuring a series of expert-led lectures that will seamlessly link the latest scientific evidence on CAR-T therapy across a range of hematologic malignancies with panel-based insights on clinical decision-making. Each session will include a Tumor Board segment designed to reflect real-world clinical experiences and decision challenges, from identifying patient candidates to appropriate follow-up and the management of a unique spectrum of adverse events. Upon completion of this CE activity, participants will be able to: Evaluate the latest clinical evidence on the safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies in patients with hematological malignancies across existing and potential future indications; Adopt best practices for integrating CAR-T therapy into the care of patients with hematologic malignancies, including appropriate patient selection, referral to specialized treatment centers, clinical trial enrollment, and provision of post-treatment follow-up care; and Develop appropriate adverse event management strategies for patients with hematological malignancies who are experiencing toxicity (eg, cytokine release syndrome or neurotoxicity) while receiving CAR-T therapy.

Go online to PeerView.com/XZA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. This unique video-based activity will offer learners a window into practice by featuring a series of expert-led lectures that will seamlessly link the latest scientific evidence on CAR-T therapy across a range of hematologic malignancies with panel-based insights on clinical decision-making. Each session will include a Tumor Board segment designed to reflect real-world clinical experiences and decision challenges, from identifying patient candidates to appropriate follow-up and the management of a unique spectrum of adverse events. Upon completion of this CE activity, participants will be able to: Evaluate the latest clinical evidence on the safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies in patients with hematological malignancies across existing and potential future indications; Adopt best practices for integrating CAR-T therapy into the care of patients with hematologic malignancies, including appropriate patient selection, referral to specialized treatment centers, clinical trial enrollment, and provision of post-treatment follow-up care; and Develop appropriate adverse event management strategies for patients with hematological malignancies who are experiencing toxicity (eg, cytokine release syndrome or neurotoxicity) while receiving CAR-T therapy.

Go online to PeerView.com/XZA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. This unique video-based activity will offer learners a window into practice by featuring a series of expert-led lectures that will seamlessly link the latest scientific evidence on CAR-T therapy across a range of hematologic malignancies with panel-based insights on clinical decision-making. Each session will include a Tumor Board segment designed to reflect real-world clinical experiences and decision challenges, from identifying patient candidates to appropriate follow-up and the management of a unique spectrum of adverse events. Upon completion of this CE activity, participants will be able to: Evaluate the latest clinical evidence on the safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies in patients with hematological malignancies across existing and potential future indications; Adopt best practices for integrating CAR-T therapy into the care of patients with hematologic malignancies, including appropriate patient selection, referral to specialized treatment centers, clinical trial enrollment, and provision of post-treatment follow-up care; and Develop appropriate adverse event management strategies for patients with hematological malignancies who are experiencing toxicity (eg, cytokine release syndrome or neurotoxicity) while receiving CAR-T therapy.

Go online to PeerView.com/XZA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. This unique video-based activity will offer learners a window into practice by featuring a series of expert-led lectures that will seamlessly link the latest scientific evidence on CAR-T therapy across a range of hematologic malignancies with panel-based insights on clinical decision-making. Each session will include a Tumor Board segment designed to reflect real-world clinical experiences and decision challenges, from identifying patient candidates to appropriate follow-up and the management of a unique spectrum of adverse events. Upon completion of this CE activity, participants will be able to: Evaluate the latest clinical evidence on the safety and efficacy of chimeric antigen receptor (CAR)-T cell therapies in patients with hematological malignancies across existing and potential future indications; Adopt best practices for integrating CAR-T therapy into the care of patients with hematologic malignancies, including appropriate patient selection, referral to specialized treatment centers, clinical trial enrollment, and provision of post-treatment follow-up care; and Develop appropriate adverse event management strategies for patients with hematological malignancies who are experiencing toxicity (eg, cytokine release syndrome or neurotoxicity) while receiving CAR-T therapy.

Today Krista and I are sharing three activities that we will doing together during our year-end review and planning meeting. While these activities aren't the only things we'll be discussing, we thought it would be more helpful to give y'all an idea of what sorts of things we focus on during these meetings vs. how to plan the meeting (more on that in a minute).We discuss an activity that will help kick things off and set the tone for the meeting that analyzes both the revenue driving activities of the business and how the team feels about those activities. Then we jump into an overview of how we examine our finances. We don't go into great detail because I'm releasing an episode in a few weeks with financial expert Shanna Skidmore who helps us explore this. And we end by discussing some of the marketing related efforts that we're going to take another look at.We have a few goals during these sorts of meetings. One is efficiency. And by that, I mean we want to figure out how we can do more with less—which ultimately means that we're figuring out what we can eliminate so as to make better use of our time and resources. It can be difficult cutting things out, but it's always amazing to me the growth that a little pruning can bring about. Beyond that, we of course want to create some space to get on the same page and dream together a bit about what the next year could look like.Sometimes the middle of these conversations aren't always easy—especially if you have a partner that you work alongside—they might have a totally different assessment of the year and what should be done the following year. God knows that has occasionally been the case with Krista and me… but these conversations are so necessary to have, and I'm always so grateful afterwards for having had them.There are so many ways to make your year-end review or planning meetings more effective. We don't jump into actually how to plan these reviews, although we do have other episodes that cover such things. Regardless of what your end-of-year meeting looks like, we hope you find one or more of these activities helpful.As always, links and resources can be found in the show notes. Check ‘em out at https://daveyandkrista.com/ And if you enjoyed this episode, please consider leaving a review over at Apple Podcasts.Find it quickly here (in the podcast):0:00 Intro4:31 Year end review7:31 Graph with four quadrants to help evaluate goals8:43 Upper left quadrant, things that drive revenue but you don't want to be doing8:57 Upper right quadrant, things that drive revenue and you want to be doing9:06 Lower right quadrant, things that you want to be doing but aren't driving revenue9:11 Lower left quadrant, things that don't drive revenue and you don't want to be doing14:23 Financial evaluation16:59 Freedom to cancel a tool you once purchased18:15 Helps to keep track of expenses throughout the year20:57 Marketing evaluation25:05 Evaluate relevant content frequently

Going forward, make the choice and commitment to make giving part of your monthly budget. Choose a cause that you and your family identify with and make it a habit. Rather than looking at charitable giving as an afterthought or “if I have anything left over to give”, make it a habit and automate your giving.  Want Medicine Revived Morning Rounds delivered to your inbox every weekday morning? Sign up for the FREE Medicine Revived Morning Rounds email at https://courses.medicinerevived.com/morning-rounds

About Today's GuestMary Reding is a government affairs exec with diverse private sector, non-profit, and public sector experience. Government experience includes leading the Office of Executive Councils and managing the development, implementation, and setting performance standards for management initiatives across the center of government through the ten C-Suite Executive boards including the President's Management Council, Chief Financial Officers Council, Chief Information Officers Council, and the Performance Improvement Council. Mary now continues the #goodgov work at Grant Thornton Public Sector focusing on improving efficiencies for our Veteran's community at the VA and across the Defense portfolio.In addition to government service, Mary has a foundation in corporate law and non-profits serving as in-house counsel for Pebble Beach Company (www.pebblebeach.com) and leading international IT transformation team for Aviva Corporate (www.aviva.com).Mary started advocating for licensing accommodations in 2010 and created the Military Spouse JD Network in 2011 and served as the founding President. Lobbying efforts were recognized by the DC Women's Bar (awarded the DC “Star of the Bar”) and by the American Bar Association (honored w/ Grassroots Advocacy award for MSJDN).The development of the workforce matters to Mary and she has mentored rising stars in business, in the military community, and in government through the creation of the CXO Fellows program and Homefront Rising. In 2018, Mary was selected as a Presidential Leadership Scholar building a bi-partisan community to solve our nation's most important problems. And… she has the best volunteer job ever – Girl Scout troop leader.Links Mentioned In This EpisodeMilitary Spouse JD NetworkMilitary Spouse JD Network FoundationHome Front RisingPsychArmor Resource of the WeekThe PsychArmor Resource of the Week is the PsychArmor course, Legal Issues and Documents Caregivers Need. This course provides ideas for the kinds of legal issues a caregiver will want to be aware of, what conversations to have with your service member or Veteran, and what documents caregivers might need to have handy for long-term care. You can find a link to the resource here: https://learn.psycharmor.org/courses/legal-issues-documents-caregivers-need   This Episode Sponsored By: This episode is sponsored by PsychArmor, the premier education and learning ecosystem specializing in military culture content. PsychArmor offers an online e-learning laboratory with custom training options for organizations.Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on TwitterPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families.  You can find more about the work that he is doing at www.veteranmentalhealth.com  

Up and coming online creator, podcaster and community builder Jay Clouse is back on the podcast sharing all the lessons he's learned bringing his online creator business to be on track for over a quarter-million dollars this year in 2022.In This Episode00:00 - Introduction01:50 - Greeting to Jay06:38 - Diversifying thoughts10:24 - Learning without regrets12:15 - Evaluate by quarter13:41 - Pricing mindset16:22 - How to find sales22:30 - Selling on Social Media31:29 - Keeping others in mind35:13 - One-off courses38:44 - Creator who offers services44:08 - Discovery platform strategy49:47 - Social ads54:24 - Balance of time & money1:02:46 - Moments of gratification1:05:28 - Motivational minuteGet all links, resources and show notes at:https://joshhall.co/228

Chelsea and I continue our chat about parenting. Parents--even Christian ones--are ever too prone to treating their children reflexively. We need to be conscious of our motives when we interact with our children and the times we have to resort to discipline. We discuss five questions we can ask ourselves to evaluate our parenting: Are we putting our feelings first (and suppressing our children's)? Are we placing guilt on our children? Are we giving our children the silent treatment? Are we ignoring healthy boundaries? Are we holding our children responsible for our happiness? Scriptures Cited: Proverbs 19:11 Isaiah 42:14 Ecclesiastes 7:10 1 Corinthians 13:4-7 Proverbs 14:29 Proverbs 11:29 *** Castle Rock Women's Health is a pro-life and pro-women health care ministry. They need your help to move into a new office to serve the community better. Please consider a monthly or one-time donation. *** We value your feedback! Have questions for Truthspresso? Contact us!

In order to lead your business and other you first must learn to lead yourself.    In this episode, I share 3 ways to lead your mindset like a C.E.O Observe your thoughts  Evaluate your thoughts  Rewire your thoughts  I'll also share why you may still feel overwhelmed in your business despite gaining skills and education as a business owner.  Ready to take your leadership skills to the next level?  Book a discovery call to see how I can support you this year:   

Chelsea and I continue our chat about parenting.Parents--even Christian ones--are ever too prone to treating their children reflexively. We need to be conscious of our motives when we interact with our children and the times we have to resort to discipline.We discuss five questions we can ask ourselves to evaluate our parenting:Are we putting our feelings first (and suppressing our children's)?Are we placing guilt on our children?Are we giving our children the silent treatment?Are we ignoring healthy boundaries?Are we holding our children responsible for our happiness?Scriptures Cited:Proverbs 19:11Isaiah 42:14Ecclesiastes 7:101 Corinthians 13:4-7Proverbs 14:29Proverbs 11:29*** Castle Rock Women's Health is a pro-life and pro-women health care ministry. They need your help to move into a new office to serve the community better. Please consider a monthly or one-time donation. ***We value your feedback!Have questions for Truthspresso? Contact us!

England wasn't its sharpest and the US played inspired soccer. With passionate play from US Captain Tyler Adams, Weston McKennie and Yunus Musah the US kept England off balance but missed a couple of huge opportunities including one off the crossbar by Christian Pulisic. Controversy still surrounds the lack of minutes for Brenden Aaronson and Gio Reyna. Begs the question, even when the team is playing this well, shouldn't we have our absolute best squad on the field? The boys need goals…period. Sets up a huge do-or-die game on Tuesday against Iran, who beat Wales 2-0.

ED is a downer and so is depression! But the two are more linked than previously thought and the two impact each other in a vicious cycle. In this episode, we'll look at the systems critical for function and the hormones and chemicals associated with maintaining an erection, and how depression affects it. [00:00 - 02:44] ED and Depression: How They Interrelate and Play NegativelyWhile ED can lead to mental health issues such as anxiety and depression, people with depression are more likely to develop ED. Arousal, initiation, and desire all start in the brain or nervous system which triggers an erection. [02:45 - 07:37] Six Systems That Are Critical for FunctionThe six systems that are involved in sexual function are the brain, emotions, hormones, nerves, blood vessels, and muscles.When the brain releases hormones, those chemicals control a reaction that affects pleasure. It is common for men to use medication or alcohol to boost their confidence artificial however this can lead to an endless cycle of ED, deppressions, and more erectile issues caused by the medication or alcohol.Exercise, diet, meditation, socializing, and communication all play a role in boosting your mood.ED is treatable and reversible! Join the Modern Man Club [07:38 - 11:39] Increase your Testosterone by Correcting Your Sleep, Diet, and LifestyleIf you have ED, see a doctor and get blood work done to assess where to go from there.Examine your diet: Eat a Mediterranean diet of more fruits, vegetables, and inflammatory foods. Examine the amount of sleep and the quality of sleep you get. Evaluate your lifestyle and make some small changes along the way. Have hope! ED is reversible and you deserve to live a life of happiness and prosperity. Quotes:“The brain releases hormones and chemicals that control the whole reaction downward. Even if it involves something that is joyful and pleasurable as sex." – Dr. Anne Truong“There are six systems that interplay; The brain, emotions, hormones, blood vessels, and muscles. These six systems are critical for function." – Dr. Anne Truong “If you keep doing the same things, you're gonna get the same results." – Dr. Anne TruongWant to regain control of your sex life? It's time to reverse the effects of ED on your life. Join the Modern Man Club and start your road to full recovery and community. For all links and resources mentioned on the show and where to subscribe to the podcast, please visit https://sexualhealthformenpodcast.com/over-the-counter-ed-pills.Reveal the FREE treatment most men ignore that solves thousands of erectile dysfunction cases every year, plus the 5 biggest mistakes you must avoid if you want to say goodbye to your ED. Uncover it all in my free ebook, available to download now.https://ed.truongrehab.com/ebook?utm_source=podcastandutm

On today's episode Bill and Kenny sit down to discuss why they believe you should be evaluating your properties performance. You don't want to miss it! Contact Tyler Coon and his team to get your next Short-Term Rental property under contract! You can find Bill online at: https://www.facebook.com/groups/284886002732508 - The Free Build STR Wealth Facebook Group Build STR Wealth BK Hot Picks STR UNFILTERED Instagram: @BillFaeth73 Tik Tok: @bfaeth You can find Kenny online at: https://strinsights.com/ Instagram: @strinsights Learn more about your ad choices. Visit megaphone.fm/adchoices

With J. Ansari, Executive Vice President at Compak Asset Management

Jules, Rachel, and Stephanie chat about: how rejection can make you better and ways to handle rejection If you have a question you'd like us to discuss feel free to  email us at hello@artistssoar.com Key Talking Points Julie has changed her mindset to realize that you have to get a ton of 'Nos" before you get a yes.   Recognize when you are experiencing imposter syndrome.  You have to take the gut punch of rejection and keep going. Turn the negative into a positive.   You have to have a failure rate, and take the shots. Evaluate and talk with other artists to see what is working for others. Have some friends mill about in your booth to pique interest.  Do not be on your phone! Consider giving a survey to find out what the audience or email subscriber wants. Test different ways of doing things (A/B testing). Mindset is the #1 thing to watch. #2 Figure out how to turn it into a positive Consider having a document that you can actually write what you want to say to get it out of the way (never share) Create a "Fabulous File" to put all of the positive things people have said about your work.  Write down what hurt you and burn the note. We'd love to hear what you do to handle rejection, email us at hello@artistssoar.com  Rise with us! On Artists Soar! For More Information and Fabulous Resources: For the Art Business Checklist go to: https://www.stephanieweaverartist.com/art-business-checklist Hotjar - a software that helps you see what people are doing for your A/B testing on your website.   Our Websites and Shops Are you an avid reader?  Then sign up for Rachel's newsletter here: https://bubblybibbly.com/ Love illustrations and bright colors?  Then sign up for Jule's newsletter here: https://www.juliemstudios.com/ Want to learn how to paint, or be part of a growing and active community? Or just love painting? Then sign up for Stephanie's newsletter here: https://www.stephanieweaverartist.com/artist-newsletter Got a Listener Question?  Email us at: hello@artistssoar.com

Go online to PeerView.com/WGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Bruton tyrosine kinase (BTK) inhibitors may soon augment the current armamentarium of DMTs for MS. Four BTK inhibitors are currently in phase 3 trials, generating great interest due to their capacity to reach therapeutic concentrations in the central nervous system and ability to affect processes mediated by B cells and microglia that contribute to the inflammatory and neurodegenerative processes that drive MS. In this activity, an expert reviews the rationale for and shares the latest findings on the efficacy, safety, and tolerability of this promising line of treatment. Upon completion of this activity, participants should be better able to: Explain the rationale for inhibiting BTK to treat MS; Evaluate the current evidence regarding the efficacy, safety, and tolerability of BTK inhibitors being studied for the treatment of MS; and Identify patients who may benefit by treatment with BTK inhibitors, based on current evidence and individual treatment needs and priorities.

Go online to PeerView.com/WGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Bruton tyrosine kinase (BTK) inhibitors may soon augment the current armamentarium of DMTs for MS. Four BTK inhibitors are currently in phase 3 trials, generating great interest due to their capacity to reach therapeutic concentrations in the central nervous system and ability to affect processes mediated by B cells and microglia that contribute to the inflammatory and neurodegenerative processes that drive MS. In this activity, an expert reviews the rationale for and shares the latest findings on the efficacy, safety, and tolerability of this promising line of treatment. Upon completion of this activity, participants should be better able to: Explain the rationale for inhibiting BTK to treat MS; Evaluate the current evidence regarding the efficacy, safety, and tolerability of BTK inhibitors being studied for the treatment of MS; and Identify patients who may benefit by treatment with BTK inhibitors, based on current evidence and individual treatment needs and priorities.

Go online to PeerView.com/WGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Bruton tyrosine kinase (BTK) inhibitors may soon augment the current armamentarium of DMTs for MS. Four BTK inhibitors are currently in phase 3 trials, generating great interest due to their capacity to reach therapeutic concentrations in the central nervous system and ability to affect processes mediated by B cells and microglia that contribute to the inflammatory and neurodegenerative processes that drive MS. In this activity, an expert reviews the rationale for and shares the latest findings on the efficacy, safety, and tolerability of this promising line of treatment. Upon completion of this activity, participants should be better able to: Explain the rationale for inhibiting BTK to treat MS; Evaluate the current evidence regarding the efficacy, safety, and tolerability of BTK inhibitors being studied for the treatment of MS; and Identify patients who may benefit by treatment with BTK inhibitors, based on current evidence and individual treatment needs and priorities.

Go online to PeerView.com/WGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Bruton tyrosine kinase (BTK) inhibitors may soon augment the current armamentarium of DMTs for MS. Four BTK inhibitors are currently in phase 3 trials, generating great interest due to their capacity to reach therapeutic concentrations in the central nervous system and ability to affect processes mediated by B cells and microglia that contribute to the inflammatory and neurodegenerative processes that drive MS. In this activity, an expert reviews the rationale for and shares the latest findings on the efficacy, safety, and tolerability of this promising line of treatment. Upon completion of this activity, participants should be better able to: Explain the rationale for inhibiting BTK to treat MS; Evaluate the current evidence regarding the efficacy, safety, and tolerability of BTK inhibitors being studied for the treatment of MS; and Identify patients who may benefit by treatment with BTK inhibitors, based on current evidence and individual treatment needs and priorities.

Go online to PeerView.com/WGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Bruton tyrosine kinase (BTK) inhibitors may soon augment the current armamentarium of DMTs for MS. Four BTK inhibitors are currently in phase 3 trials, generating great interest due to their capacity to reach therapeutic concentrations in the central nervous system and ability to affect processes mediated by B cells and microglia that contribute to the inflammatory and neurodegenerative processes that drive MS. In this activity, an expert reviews the rationale for and shares the latest findings on the efficacy, safety, and tolerability of this promising line of treatment. Upon completion of this activity, participants should be better able to: Explain the rationale for inhibiting BTK to treat MS; Evaluate the current evidence regarding the efficacy, safety, and tolerability of BTK inhibitors being studied for the treatment of MS; and Identify patients who may benefit by treatment with BTK inhibitors, based on current evidence and individual treatment needs and priorities.

Content features quite highly in most ecommerce platform RFPs, especially with brands looking to focus on customer experience and not just commerce capability. Vendors talk about their page builders whereas businesses are expecting a CMS (content management system). In this ecommerce podcast we look at valid use cases for when investment in a specialist CMS is required because native page builders can't satisfy the business needs. Please note by native page builder, we mean the inbuilt page builders on market leading ecommerce platforms such as Salesforce Commerce Cloud, Adobe Commerce, Shopify Plus, Big Commerce and Shopware. We cover what native page builders can do and when the page builder is sufficient for an ecommerce business, what page builders can't do that a specialist CMS can and how you can meaningfully evaluate a CMS to build the business case for investment.

About Today's GuestAbby Malchow is the Sr. Business Development Manager of Small Business Partnerships for Small Business Empowerment at Amazon helps drive the success of small businesses and underserved business populations (including minority-, women-, and veteran-owned businesses). Additionally, Abby serves on the Global Board of Directors at Amazon for Mental Health & Well-Being (MHW) as the Director of Corporate Strategy. Abby helped launch MHW in April 2020 as Amazon's 13th Affinity Group and in nine months MHW grew by a rate of 600% and currently has over 18K members from 27 countries across the globe. Prior to joining Amazon, Abby worked at Intel Corporation and is a retired U.S. Navy Chief and combat veteran, serving more than 20 years in the military.Abby has been a passionate advocate for veteran suicide prevention since 2014 when she was one of the 22 veterans selected by Iraq and Afghanistan Veterans of America (IAVA) to advocate to Congress for support of the Clay Hunt Suicide Prevention for America's Veterans Act, which was signed into law by President Obama on February 12th, 2015. Additionally, she is a 2018 alum of the inaugural cohort of President George W. Bush's Stand-To Veteran Leadership Program where she worked in collaboration with Intel's “AI for Good” team on developing Machine Learning (ML) models on social media platforms to provide targeted suicide prevention to veterans. More recently in 2020, she led a project at Amazon in collaboration with the AWS ML Solutions Lab which built a ML model for RallyPoint that will allow them to quickly identify posts that indicate a high risk of self-harm to enable potentially life-saving intervention.Abby is a graduate of the University of Maryland, Robert H. Smith School of Business, where she earned a Master of Business Administration degree. She also holds a B.B.A. (cum laude) in Business Administration from the University of San Diego.  Links Mentioned In This EpisodeAmazon Small Business Partnerships Contact EmailAmazon Small Business Impact ReportAmazon Small Business StorefrontsAmazon Small Business AcademyAmazon Seller UniversityPsychArmor Resource of the WeekThe PsychArmor Resource of the Week is the PsychArmor course, Supporting Veteran-Owned Businesses: Supplier Diversity, In this course, you will learn strategies and best practices to implement Veteran supplier diversity in your business or organization. You can find a link to the resource here: https://learn.psycharmor.org/courses/Supporting-Veteran-Owned-Businesses  This Episode Sponsored By: This episode is sponsored by PsychArmor, the premier education and learning ecosystem specializing in military culture content. PsychArmor offers an online e-learning laboratory with custom training options for organizations.Contact Us and Join Us on Social Media Email PsychArmorPsychArmor on TwitterPsychArmor on FacebookPsychArmor on YouTubePsychArmor on LinkedInPsychArmor on InstagramTheme MusicOur theme music Don't Kill the Messenger was written and performed by Navy Veteran Jerry Maniscalco, in cooperation with Operation Encore, a non profit committed to supporting singer/songwriter and musicians across the military and Veteran communities.Producer and Host Duane France is a retired Army Noncommissioned Officer, combat veteran, and clinical mental health counselor for service members, veterans, and their families.  You can find more about the work that he is doing at www.veteranmentalhealth.com  

Go online to PeerView.com/WGE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Bruton tyrosine kinase (BTK) inhibitors may soon augment the current armamentarium of DMTs for MS. Four BTK inhibitors are currently in phase 3 trials, generating great interest due to their capacity to reach therapeutic concentrations in the central nervous system and ability to affect processes mediated by B cells and microglia that contribute to the inflammatory and neurodegenerative processes that drive MS. In this activity, an expert reviews the rationale for and shares the latest findings on the efficacy, safety, and tolerability of this promising line of treatment. Upon completion of this activity, participants should be better able to: Explain the rationale for inhibiting BTK to treat MS; Evaluate the current evidence regarding the efficacy, safety, and tolerability of BTK inhibitors being studied for the treatment of MS; and Identify patients who may benefit by treatment with BTK inhibitors, based on current evidence and individual treatment needs and priorities.